Novel treatment of excitotoxicity: Targeted disruption of intracellular signalling from glutamate receptors

Biochemical Pharmacology

Volumn 66, Issue 6, 2003, Pages 877-886

  Aarts, Michelle M ^a,b,c   Tymianski, Michael ^a,b  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c TORONTO WESTERN HOSPITAL   (Canada)

Author keywords

Excitotoxicity; Glutamate receptors; Intracellular signalling; Neurological disorders

Indexed keywords

AMPA RECEPTOR; CALCIUM; CELL PROTEIN; GLUTAMATE RECEPTOR; IONOTROPIC RECEPTOR; MEMBRANE RECEPTOR; METABOTROPIC RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PEPTIDE;

BRAIN NERVE CELL; CYTOSKELETON; CYTOTOXICITY; DENSITY; DRUG EFFECT; DRUG TARGETING; IN VIVO STUDY; INTRACELLULAR SPACE; MOLECULAR INTERACTION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN FAMILY; REVIEW; SIGNAL TRANSDUCTION; SYNAPSE;

EID: 0042762828     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(03)00297-1     Document Type: Note

References (132)

1. Ikonomidou C., Turski L. Why did NMDA receptor antagonists fail clinical trials for stroke and traumatic brain injury? Lancet Neurol. 1:2002;383-386.
2. Lucas D.R., Newhouse J.P. The toxic effect of sodium L-glutamate on the inner layers of the retina. Arch. Ophthalmol. 58:1957;193-201.
3. Olney J.W. Brain lesions, obesity, and other disturbances in mice treated with monosodium glutamate. Science. 164:1969;719-721.
4. Olney J.W., Ho O.L. Brain damage in infant mice following oral intake of glutamate, aspartate or cysteine. Nature. 227:1970;609-611.
5. Kass I.S., Lipton P. Mechanisms involved in irreversible anoxic damage to the in vitro rat hippocampal slice. J. Physiol. 332:1982;459-472.
6. Rothman S.M. Synaptic activity mediates death of hypoxic neurons. Science. 220:1983;536-537.
7. Pin J.P., Duvoisin R. The metabotropic glutamate receptors: structure and functions. Neuropharmacology. 34:1995;1-26.
8. Conn P.J., Pin J.P. Pharmacology and functions of metabotropic glutamate receptors. Annu. Rev. Pharmacol. Toxicol. 37:1997;205-237.
9. Gerber U., Sim J.A., Gahwiler B.H. Reduction of potassium conductances mediated by metabotropic glutamate receptors in rat CA3 pyramidal cells does not require protein kinase C or protein kinase A. Eur. J. Neurosci. 4:1992;792-797.
10. Crepel V., Aniksztejn L., Ben Ari Y., Hammond C. Glutamate metabotropic receptors increase a Ca(2+)-activated non-specific cationic current in CA1 hippocarnpal neurons. J. Neurophysiol. 72:1994;1561-1569.
11. Chong Z.Z., Kang J.Q., Maiese K. Metabotropic glutamate receptors promote neuronal and vascular plasticity through novel intracellular pathways. Histol. Histopathol. 18:2003;173-189.
12. Hoffpauir B.K., Gleason E.L. Activation of mGluR5 modulates GABA(A) receptor function in retinal amacrine cells. J. Neurophysiol. 88:2002;1766-1776.
13. Madden D.R. The structure and function of glutamate receptor ion channels. Nat. Rev. Neurosci. 3:2002;91-101.
14. Cull-Candy S., Brickley S., Farrant M. NMDA receptor subunits: diversity, development and disease. Curr. Opin. Neurobiol. 11:2001;327-335.
15. Wisden W., Seeburg P.H. Mammalian ionotropic glutamate receptors. Curr. Opin. Neurobiol. 3:1993;291-298.
16. Kind P.C., Neumann P.E. Plasticity: downstream of glutamate. Trends Neurosci. 24:2001;553-555.
17. Sheng M., Kim M.J. Postsynaptic signaling and plasticity mechanisms. Science. 298:2002;776-780.
18. Choi D.W. Calcium-mediated neurotoxicity: relationship to specific channel types and role in ischemic damage. Trends Neurosci. 11:1988;465-469.
19. Hollmann M., Heinemann S. Cloned glutamate receptors. Annu. Rev. Neurosci. 17:1994;31-108.
20. 2+ permeability of KA-AMPA-gated glutamate receptor channels depends on subunit composition. Science. 252:1991;851-853.
21. Hume R.I., Dingledine R., Heinemann S.F. Identification of a site in glutamate receptor subunits that controls calcium permeability. Science. 253:1991;1028-1031.
22. Sommer B., Kohler M., Sprengel R., Seeburg P.H. RNA editing in brain controls a determinant of ion flow in glutamate-gated channels. Cell. 67:1991;11-19.
23. 2+ influx in hippocampal CA1 neurons of gerbil. J. Neurosci. 17:1997;6179-6188.
24. Pellegrini-Giampietro D.E., Gorter J.A., Bennett M.V., Zukin R.S. The GluR2 (GluR-B) hypothesis: Ca(2+)-permeable AMPA receptors in neurological disorders. Trends Neurosci. 20:1997;464-470.
25. Kanellopoulos G.K., Xu X.M., Hsu C.Y., Lu X., Sundt T.M., Kouchoukos N.T. White matter injury in spinal cord ischemia: protection by AMPA/kainate glutamate receptor antagonism. Stroke. 31:2000;1945-1952.
26. McCracken E., Fowler J.H., Dewar D., Morrison S., McCulloch J. Grey matter and white matter ischemic damage is reduced by the competitive AMPA receptor antagonist, SPD 502. J. Cereb. Blood Flow Metab. 22:2002;1090-1097.
27. McDonald J.W., Althomsons S.P., Hyrc K.L., Choi D.W., Goldberg M.P. Oligodendrocytes from forebrain are highly vulnerable to AMPA/kainate receptor-mediated excitotoxicity. Nat. Med. 4:1998;291-297.
28. Mori I.I., Mishina M. Structure and function of the NMDA receptor channel. Neuropharmacology. 34:1995;1219-1237.
29. Moriyoshi K., Masu M., Ishii T., Shigemoto R., Mizuno N., Nakanishi S. Molecular cloning and characterization of the rat NMDA receptor. Nature. 354:1991;31-37.
30. Ciabarra A.M., Sullivan J.M., Gahn L.G., Pecht G., Heinemann S., Sevarino K.A. Cloning and characterization of chi-1: a developmentally regulated member of a novel class of the ionotropic glutamate receptor family. J. Neurosci. 15:1995;6498-6508.
31. Sucher N.J., Akbarian S., Chi C.L., Leclerc C.L., Awobuluyi M., Deitcher D.L., Wu M.K., Yuan J.P., Jones E.G., Lipton S.A. Developmental and regional expression pattern of a novel NMDA receptor-like subunit (NMDAR-L) in the rodent brain. J. Neurosci. 15:1995;6509-6520.
32. Dale N., Roberts A. Dual-component amino-acid-mediated synaptic potentials: excitatory drive for swimming in Xenopus embryos. J. Physiol. 363:1985;35-59.
33. Kaku D.A., Goldberg M.P., Choi D.W. Antagonism of non-NMDA receptors augments the neuroprotective effect of NMDA receptor blockade in cortical cultures subjected to prolonged deprivation of oxygen and glucose. Brain Res. 554:1991;344-347.
34. Tymianski M., Charlton M.P., Carlen P.L., Tator C.H. Source specificity of early calcium neurotoxicity in cultured embryonic spinal neurons. J. Neurosci. 13:1993;2085-2104.
35. Rahn C.A., Bombick D.W., Doolittle D.J. Assessment of mitochondrial membrane potential as an indicator of cytotoxicity. Fundam. Appl. Toxicol. 16:1991;435-448.
36. Bindonkas V.P., Miller R.J. Excitotoxic degeneration is initiated at non-random sites in cultured rat cerebellar neurons. J. Neurosci. 15:1995;6999-7011.
37. Choi D.W. Ionic dependence of glutamate neurotoxicity. J. Neurosci. 7:1987;369-379.
38. Choi D.W. Calcium: still center-stage in hypoxic-ischemic neuronal death. Trends Neurosci. 18:1995;58-60.
39. Tymianski M. Cytosolic calcium concentrations and cell death in vitro. Adv. Neurol. 71:1996;85-105.
40. Choi D.W., Maulucci-Gedde M., Kriegstein A.R. Glutamate neurotoxicity in cortical cell culture. J. Neurosci. 7:1987;357-368.
41. Choi D.W. Glutamate neurotoxicity in cortical cell culture is calcium dependent. Neurosci. Lett. 58:1985;293-297.
42. 45Calcium accumulation and intracellular calcium during in vitro "ischemia" Soc. Neurosci. Abstr. 15:1989;803. [abstract].
43. Goldberg M.P., Choi D.W. Intracellular free calcium increases in cultured cortical neurons deprived of oxygen and glucose. Stroke. 21:1990;III75-III77.
44. 2+ influx elicited by glutamate: role in neuronal death. Mol. Pharmacol. 36:1989;106-112.
45. Marcoux F.W., Probert A.W. Jr., Weber M.L. Hypoxic neuronal injury in tissue culture is associated with delayed calcium accumulation. Stroke. 21:1990;III71-III74.
46. Choi D.W., Weiss J.H., Koh J.Y., Christine C.W., Kurth M.C. Glutamate neurotoxicity, calcium, and zinc. Ann. N.Y. Acad. Sci. 568:1989;219-224.
47. Madden K.P., Clark W.M., Marcoux F.W., Probert A.W. Jr., Weber M.L., Rivier J., Zivin J.A. Treatment with conotoxin, an 'N-type' calcium channel blocker, in neuronal hypoxic-ischemic injury. Brain Res. 537:1990;256-262.
48. Marcoux F.W., Weber M.L., Probert A.W. Jr., Dominick M.A. Hypoxic neurodegeneration in culture: calcium influx, electron microscopy, and neuroprotection with excitatory amino acid antagonists. Ann. N.Y. Acad. Sci. 648:1992;303-305.
49. Marcoux FW, Probert AW, Weber ML. Hypoxic neural injury in cell culture: calcium accumulation blockade and neuroprotection by NMDA antagonists but not calcium channel antagonists. In: Ginsberg MD, Dietrich WD, editors. Cerebrovascular Disease: Sixteenth Princeton Conference. New York: Raven Press; 1989. p. 135-41.
50. Dubinsky J.M., Rothman S.M. Intracellular calcium concentrations during "chemical hypoxia" and excitotoxic neuronal injury. J. Neurosci. 11:1991;2545-2551.
51. Bading H., Ginty D.D., Greenberg M.E. Regulation of gene expression in hippocampal neurons by distinct calcium signaling pathways. Science. 260:1993;181-186.
52. Ghosh A., Greenberg M.E. Calcium signalling in neurons: molecular mechanisms and cellular consequences. Science. 268:1995;239-247.
53. Sattler R., Charlton M.P., Hafner M., Tymianski M. Distinct influx pathways, not calcium load, determine neuronal vulnerability to calcium neurotoxicity. J. Neurochem. 71:1998;2349-2364.
54. Kennedy M.B. The postsynaptic density at glutamatergic synapses. Trends Neurosci. 20:1997;264-268.
55. Carlin R.K., Grab D.J., Cohen R.S., Siekevitz P. Isolation and characterization of postsynaptic densities from various brain regions: enrichment of different types of postsynaptic densities. J. Cell Biol. 86:1980;831-845.
56. Landis D.M., Reese T.S. Differences in membrane structure between excitatory and inhibitory synapses in the cerebellar cortex. J. Comp. Neurol. 155:1974;93-125.
57. Kennedy M.B. The postsynaptic density. Curr. Opin. Neurobiol. 3:1993;732-737.
58. Beesley P.W., Mummery R., Tibaldi J. N-cadherin is a major glycoprotein component of isolated rat forebrain postsynaptic densities. J. Neurochem. 64:1995;2288-2294.
59. Kennedy M.B. Signal transduction molecules at the glutamatergic postsynaptic membrane. Brain Res. Brain Res. Rev. 26:1998;243-257.
60. Irie M., Hata Y., Takeuchi M., Ichtchenko K., Toyoda A., Hirao K., Takai Y., Rosahl T.W., Suedhof T.C. Binding of neuroligins to PSD-95. Science. 277:1997;1511-1515.
61. Nusser Z., Mulvihill E., Streit P., Somogyi P. Subsynaptic segregation of metabotropic and ionotropic glutamate receptors as revealed by immunogold localization. Neuroscience. 61:1994;421-427.
62. Tu J.C., Xiao B., Naisbitt S., Yuan J.P., Petralia R.S., Brakeman P., Doan A., Aakalu V.K., Lanahan A.A., Sheng M., Worley P.F. Coupling of mGluR/Homer and PSD-95 complexes by the Shank family of postsynaptic density proteins. Neuron. 23:1999;583-592.
63. Lu W.Y., Xiong Z.G., Lei S., Orser B.A., Dudek E., Browning M.D., MacDonald J.F. G-protein-coupled receptors act via protein kinase C and Src to regulate NMDA receptors. Nat. Neurosci. 2:1999;331-338.
64. Moon I.S., Apperson M.L., Kennedy M.B. The major tyrosine-phosphorylated protein in the postsynaptic density fraction is N-methyl-D-aspartate receptor subunit 2B. Proc. Natl. Acad. Sci. U.S.A. 91:1994;3954-3958.
65. Baude A., Nusser Z., Molnar E., McIlhinney R.A., Somogyi P. High-resolution immunogold localization of AMPA type glutamate receptor subunits at synaptic and non-synaptic sites in rat hippocampus. Neuroscience. 69:1995;1031-1055.
66. Sprengel R., Suchanek B., Amico C., Brusa R., Burnashev N., Rozov A., Hvalby O., Jensen V., Paulsen O., Andersen P., Kim J.J., Thompson R.F., Sun W., Webster L.C., Grant S.G., Eilers J., Konnerth A., Li J., McNamara J.O., Seeburg P.H. Importance of the intracellular domain of NR2 subunits for NMDA receptor function in vivo. Cell. 92:1998;279-289.
67. Sakimura K., Kutsuwada T., Ito I., Manabe T., Takayama C., Kushiya E., Yagi T., Aizawa S., Inoue Y., Sugiyama H. Reduced hippocampal LTP and spatial learning in mice lacking NMDA receptor epsilon 1 subunit. Nature. 373:1995;151-155.
68. Barria A., Muller D., Derkach V., Griffith L.C., Soderling T.R. Regulatory phosphorylation of AMPA-type glutamate receptors by CaM-KII during long-term potentiation. Science. 276:1997;2042-2045.
69. Ehlers M.D., Tingley W.G., Huganir R.L. Regulated subcellular distribution of the NR1 subunit of the NMDA receptor. Science. 269:1995;1734-1737.
70. Wang L.Y., Dudek E.M., Browning M.D., MacDonald J.F. Modulation of AMPA/kainate receptors in cultured murine hippocampal neurones by protein kinase C. J. Physiol. 475:1994;431-437.
71. Bayer K.U., Schulnan H. Regulation of signal transduction by protein targeting: the case for CaMKII. Biochem. Biophys. Res. Commun. 289:2001;917-923.
72. Yu X.M., Askalan R., Keil G.J., Salter M.W. NMDA channel regulation by channel-associated protein tyrosine kinase Src. Science. 275:1997;674-678.
73. Wyszynski M., Lin J., Rao A., Nigh E., Beggs A.H., Craig A.M., Sheng M. Competitive binding of alpha-actinin and calmodulin to the NMDA receptor. Nature. 385:1997;439-442.
74. Osten P., Srivastava S., Inman G.J., Vilim F.S., Khatri L., Lee L.M., States B.A., Einheber S., Milner T.A., Hanson P.I., Ziff E.B. The AMPA receptor GluR2 C terminus can mediate a reversible, ATP-dependent interaction with NSF and alpha- and beta-SNAPS. Neuron. 21:1998;99-110.
75. Song I., Kamboj S., Xia J., Dong H., Liao D., Huganir R.L. Interaction of the N-ethylmaleimide-sensitive factor with AMPA receptors. Neuron. 21:1998;393-400.
76. Nishimune A., Isaac J.T., Molnar E., Noel J., Nash S.R., Tagaya M., Collingridge G.L., Nakanishi S., Henley J.M. NSF binding to GluR2 regulates synaptic transmission. Neuron. 21:1998;87-97.
77. Kornau H.C., Schenker L.T., Kennedy M.B., Seeburg P.H. Domain interaction between NMDA receptor subunits and the postsynaptic density protein PSD-95. Science. 269:1995;1737-1740.
78. Xia J., Zhang X., Staudinger J., Huganir R.L. Clustering of AMPA receptors by the synaptic PDZ domain-containing protein PICK1. Neuron. 22:1999;179-187.
79. Dong H., O'Brien R.J., Fung E.T., Lanahan A.A., Worley P.F., Huganir R.L. GRIP: a synaptic PDZ domain-containing protein that interacts with AMPA receptors. Nature. 386:1997;279-284.
80. Srivastava S., Osten P., Vilim F.S., Khatri L., Inman G., States B., Daly C., DeSouza S., Abagyan R., Valtschanoff J.G., Weinberg R.J., Ziff E.B. Novel anchorage of GluR2/3 to the postsynaptic density by the AMPA receptor-binding protein ABP. Neuron. 21:1998;581-591.
81. Sattler R., Xiong Z., Lu W.Y., Hafner M., MacDonald J.F., Tymianski M. Specific coupling of NMDA receptor activation to nitric oxide neurotoxicity by PSD-95 protein. Science. 284:1999;1845-1848.
82. Aarts M., Liu Y., Liu L., Besshoh S., Arundine M., Gurd J.W., Wang Y.T., Salter M.W., Tymianski M. Treatment of ischemic brain damage by perturbing NMDA receptor-PSD-95 protein interactions. Science. 298:2002;846-850.
83. Shin H., Hsueh Y.P., Yang F.C., Kim E., Sheng M. An intramolecular interaction between Src homology 3 domain and guanylate kinase-like domain required for channel clustering by postsynaptic density-95/SAP90. J. Neurosci. 20:2000;3580-3587.
84. Allison D.W., Chervin A.S., Gelfand V.I., Craig A.M. Postsynaptic scaffolds of excitatory and inhibitory synapses in hippocampal neurons: maintenance of core components independent of actin filaments and microtubules. J. Neurosci. 20:2000;4545-4554.
85. Aoki C., Rhee J., Lubin M., Dawson T.M. NMDA-R1 subunit of the cerebral cortex co-localizes with neuronal nitric oxide synthase at pre- and postsynaptic sites and in spines. Brain Res. 750:1997;25-40.
86. Valtschanoff J.G., Weinberg R.J. Laminar organization of the NMDA receptor complex within the postsynaptic density. J. Neurosci. 21:2001;1211-1217.
87. Kim J.H., Liao D., Lau L.F., Huganir R.L. SynGAP: a synaptic RasGAP that associates with the PSD-95/SAP90 protein family. Neuron. 20:1998;683-691.
88. Pak D.T., Yang S., Rudolph-Correia S., Kim E., Sheng M. Regulation of dendritic spine morphology by SPAR, a PSD-95-associated RapGAP. Neuron. 31:2001;289-303.
89. Zhang W., Vazquez L., Apperson M., Kennedy M.B. Citron binds to PSD-95 at glutamatergic synapses on inhibitory neurons in the hippocampus. J. Neurosci. 19:1999;96-108.
90. Sheng M. Molecular organization of the postsynaptic specialization. Proc. Natl. Acad. Sci. U.S.A. 98:2001;7058-7061.
91. Hung A.Y., Sheng M. PDZ domains: structural modules for protein complex assembly. J. Biol. Chem. 277:2002;5699-5702.
92. Kornau H.C., Seeburg P.H., Kennedy M.B. Interaction of ion channels and receptors with PDZ domain proteins. Curr. Opin. Neurobiol. 7:1997;368-373.
93. Brenman J.E., Chao D.S., Gee S.H., McGee A.W., Craven S.E., Santillano D.R., Wu Z., Huang F., Xia H., Peters M.F., Froehner S.C., Bredt D.S. Interaction of nitric oxide synthase with the postsynaptic density protein PSD-95 and alpha1-syntrophin mediated by PDZ domains. Cell. 84:1996;757-767.
94. Passafaro M., Sala C., Niethammer M., Sheng M. Microtubule binding by CRIPT and its potential role in the synaptic clustering of PSD-95. Nat. Neurosci. 2:1999;1063-1069.
95. Neithammer M., Valtschanoff J.G., Kapoor T.M., Allison D.W., Weinberg T.M., Craig A.M., Sheng M. CRIPT, a novel postsynaptic protein that binds to the third PDZ domain of PSD-95/SAP90. Neuron. 20:1998;693-707.
96. Seabold G.K., Burette A., Lim I.A., Weinberg R.J., Hell J.W. Interaction of the tyrosine kinase Pyk2 with the N-methyl-D-aspartate receptor complex via the SH3 domains of PSD-95 and SAP102. J. Biol. Chem. 278:2003;15040-15048.
97. Ehlers M.D. Synapse structure: glutamate receptors connected by the shanks. Curr. Biol. 9:1999;R848-R850.
98. Naisbitt S., Kim E., Tu J.C., Xiao B., Sala C., Valtschanoff J., Weinberg R.J., Worley P.F., Sheng M. Shank, a novel family of postsynaptic density proteins that binds to the NMDA receptor/PSD-95/GKAP complex and cortactin. Neuron. 23:1999;569-582.
99. Staudinger J., Zhou J., Burgess R., Elledge S.J., Olson E.N. PICK1: a perinuclear binding protein and substrate for protein kinase C isolated by the yeast two-hybrid system. J. Cell Biol. 128:1995;263-271.
100. Perez J.L., Khatri L., Chang C., Srivastava S., Osten P., Ziff E.B. PICK1 targets activated protein kinase Calpha to AMPA receptor clusters in spines of hippocampal neurons and reduces surface levels of the AMPA-type glutamate receptor subunit 2. J. Neurosci. 21:2001;5417-5428.
101. Niethammer M., Sheng M. Identification of ion channel-associated proteins using the yeast two-hybrid system. Methods Enzymol. 293:1998;104-122.
102. Contractor A., Heinemann S.F. Glutamate receptor trafficking in synaptic plasticity. Sci. STKE. 2002:2002;RE14.
103. Malinow R., Malenka R.C. AMPA receptor trafficking and synaptic plasticity. Annu. Rev. Neurosci. 25:2002;103-126.
104. Osten P., Khatri L., Perez J.L., Kohr G., Giese G., Daly C., Schulz T.W., Wensky A., Lee L.M., Ziff E.B. Mutagenesis reveals a role for ABP/GRIP binding to GluR2 in synaptic surface accumulation of the AMPA receptor. Neuron. 27:2000;313-325.
105. Bennett M.V., Pellegrini-Giampietro D.E., Gorter J.A., Aronica E., Connor J.A., Zukin R.S. The GluR2 hypothesis: Ca(2+)-permeable AMPA receptors in delayed neurodegeneration. Cold Spring Harb. Symp. Quant. Biol. 61:1996;373-384.
106. Takuma H., Kwak S., Yoshizawa T., Kanazawa I. Reduction of GluR2 RNA editing, a molecular change that increases calcium influx through AMPA receptors, selective in the spinal ventral gray matter of patients with amyotrophic lateral sclerosis. Ann. Neurol. 46:1999;806-815.
107. Iihara K., Joo D.T., Henderson J., Sattler R., Taverna F.A., Lourensen S., Orser B.A., Roder J.C., Tymianski M. The influence of glutamate receptor 2 expression on excitotoxicity in Glur2 null mutant mice. J. Neurosci. 21:2001;2224-2239.
108. Ye B., Liao D., Zhang X., Zhang P., Dong H., Huganir R.L. GRASP-l: a neuronal RasGEF associated with the AMPA receptor/GRIP complex. Neuron. 26:2000;603-617.
109. Ye B., Sugo N., Hum P.D., Huganir R.L. Physiological and pathological caspase cleavage of the neuronal RasGEF GRASP-1 as detected using a cleavage site-specific antibody. Neuroscience. 114:2002;217-227.
110. Sattler R., Tymianski M. Molecular mechanisms of glutamate receptor-mediated excitotoxic neuronal cell death. Mol. Neurobiol. 24:2001;107-129.
111. Migaud M., Charlesworth P., Dempster M., Webster L.C., Watabe A.M., Makhinson M., He Y., Ramsay M.F., Morris R.G.M., Morrison J.H., O'Dell T.J., Grandt S.G.N. Enhanced long-term potentiation and impaired learning in mice with mutant postsynaptic density-95 protein. Nature. 396:1998;433-439.
112. Allison D.W., Gelfand V.I., Spector I., Craig A.M. Role of actin in anchoring postsynaptic receptors in cultured hippocampal neurons: differential attachment of NMDA versus AMPA receptors. J. Neurosci. 18:1998;2423-2436.
113. Sattler R., Xiong Z., Lu W.Y., MacDonald J.F., Tymianski M. Distinct roles of synaptic and extrasynaptic NMDA receptors in excitotoxicity. J. Neurosci. 20:2000;22-33.
114. Brenman J.E., Bredt D.S. Nitric oxide signaling in the nervous system. Methods Enzymol. 269:1996;119-129.
115. Brenman J.E., Christopherson K.S., Craven S.E., McGee A.W., Bredt D.S. Cloning and characterization of postsynaptic density 93, a nitric oxide synthase interacting protein. J. Neurosci. 16:1996;7407-7415.
116. Stricker N.L., Christopherson K.S., Yi B.A., Schatz P.J., Raab R.W., Dawes G., Bassett D.E. Jr., Bredt D.S., Li M. PDZ domain of neuronal nitric oxide synthase recognizes novel C-terminal peptide sequences. Nat. Biotechnol. 15:1997;336-342.
117. Nikam S.S., Kornberg B.E. AMPA receptor antagonists. Curr. Med. Chem. 8:2001;155-170.
118. Madsen U., Stensbol T.B., Krogsgaard-Larsen P. Inhibitors of AMPA and kainate receptors. Curr. Med. Chem. 8:2001;1291-1301.
119. Ikonomidou C., Bosch F., Miksa M., Bittigau P., Vockler J., Dikranian K., Tenkova T.I., Stefovska V., Turski L., Olney J.W. Blockade of NMDA receptors and apoptotic neurodegeneration in the developing brain. Science. 283:1999;70-74.
120. Ishimaru M.J., Ikonomidou C., Tenkova T.I., Der T.C., Dikranian K., Sesma M.A., Olney J.W. Distinguishing excitotoxic from apoptotic neurodegeneration in the developing rat brain. J. Comp. Neurol. 408:1999;461-476.
121. Frankel A.D., Pabo C.O. Cellular uptake of the tat protein from human immunodeficiency virus. Cell. 55:1988;1189-1193.
122. Mann D.A., Frankel A.D. Endocytosis and targeting of exogenous HIV-1 Tat protein. EMBO J. 10:1991;1733-1739.
123. Becker-Hapak M., McAllister S.S., Dowdy S.F. TAT-mediated protein transduction into mammalian cells. Methods. 24:2001;247-256.
124. Bergmann P., Kacenelenbogen R., Vizet A. Plasma clearance, tissue distribution and catabolism of cationized albumins with increasing isoelectric points in the rat. Clin. Sci. (Lond.). 67:1984;35-43.
125. Shen W.C., Ryser H.J. Conjugation of poly-L-lysine to albumin and horseradish peroxidase: a novel method of enhancing the cellular uptake of proteins. Proc. Natl. Acad. Sci. U.S.A. 75:1978;1872-1876.
126. Lindgren M., Hallbrink M., Prochiantz A., Langel U. Cell-penetrating peptides. Trends Pharmacol. Sci. 21:2000;99-103.
127. Prochiantz A. Messenger proteins: homeoproteins, TAT and others. Curr. Opin. Cell Biol. 12:2000;400-406.
128. Derossi D., Calvet S., Trembleau A., Brunissen A., Chassaing G., Prochiantz A. Cell internalization of the third helix of the Antennapedia homeodomain is receptor-independent. J. Biol. Chem. 271:1996;18188-18193.
129. Elliott G., O'Hare P. Intercellular trafficking and protein delivery by a herpesvirus structural protein. Cell. 88:1997;223-233.
130. Schwarze S.R., Ho A., Vocero-Akbani A., Dowdy S.F. In vivo protein transduction: delivery of a biologically active protein into the mouse [see comments]. Science. 285:1999;1569-1572.
131. Pawson T. Protein modules and signalling networks. Nature. 373:1995;573-579.
132. Gadek T.R., Nicholas J.B. Small molecule antagonists of proteins. Biochem. Pharmacol. 65:2003;1-8.